Main > ENDOCRINOLOGY > DK. N. Diab. 2>Glycemic Control Ta>

---

DK. N. Diab. 2>Glycemic Control Ta>'s subsections
(*) USA Approval Date: 2019. 09.20
>GLP-1 Agonist Tablet
Company
Generic Name: Semaglutide
GLP: Glucagon-Like Peptide
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 9
Patent>UpDate: 2021. 11.23
RTM
RTM Web-Site

DK. N. Diab. 2>Glycemic Control Ta>'s products
This section has no products